Biohit Oyj B (HE:BIOBV) — Stock Price
Biohit Oyj B (HE:BIOBV) is currently trading at €2.68 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €2.21 and €3.70. This page tracks Biohit Oyj B's live share price on the HE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Biohit Oyj B.
Biohit Oyj B (BIOBV) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Biohit Oyj B's daily closing share price and trading volume on the HE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Biohit Oyj B Income Statement — Revenue, Profit & Earnings by Year
Biohit Oyj B's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €15.70 Million | €14.30 Million | €13.08 Million | €10.95 Million | €9.36 Million |
| Cost of Revenue | €9.60 Million | €5.00 Million | €4.61 Million | €3.84 Million | €3.45 Million |
| Gross Profit | €6.10 Million | €9.30 Million | €8.46 Million | €7.11 Million | €5.91 Million |
| Research & Development | — | — | €1.17 Million | €1.24 Million | €1.22 Million |
| SG&A | €4.20 Million | €4.00 Million | €3.54 Million | €1.01 Million | €1.24 Million |
| Total Operating Expenses | €2.90 Million | €6.70 Million | €6.64 Million | €5.98 Million | €7.42 Million |
| Operating Income | €3.20 Million | €2.60 Million | €1.82 Million | €1.13 Million | €-1.48 Million |
| EBITDA | €3.70 Million | €3.50 Million | €2.69 Million | €1.61 Million | €692.00K |
| EBIT | €3.20 Million | €3.20 Million | €2.33 Million | €1.13 Million | €-1.30 Million |
| Interest Expense | €100.00K | €300.00K | €131.00K | €289.00K | €9.00K |
| Income Before Tax | €2.90 Million | €2.90 Million | €2.19 Million | €868.00K | €-1.30 Million |
| Income Tax Expense | €200.00K | €300.00K | €344.00K | €267.00K | €195.00K |
| Net Income | €2.70 Million | €2.60 Million | €1.85 Million | €601.00K | €-1.50 Million |
Biohit Oyj B Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Biohit Oyj B's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €19.80 Million | €15.50 Million | €12.92 Million | €11.02 Million | €9.61 Million |
| Total Current Assets | €9.10 Million | €11.00 Million | €11.83 Million | €9.90 Million | €8.98 Million |
| Cash & Equivalents | €3.50 Million | €3.75 Million | €3.03 Million | €2.12 Million | €1.10 Million |
| Short-term Investments | €1.30 Million | €2.96 Million | €3.79 Million | €4.11 Million | €4.41 Million |
| Net Receivables | €3.60 Million | €3.20 Million | €3.66 Million | €2.75 Million | €2.72 Million |
| Inventory | €800.00K | €1.00 Million | €890.00K | €920.00K | €750.00K |
| Property, Plant & Equipment | €1.90 Million | €702.00K | €766.00K | €993.00K | €420.00K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €4.90 Million | €3.30 Million | €3.49 Million | €3.56 Million | €2.31 Million |
| Total Current Liabilities | €3.60 Million | €3.00 Million | €3.06 Million | €2.86 Million | €2.15 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | €-600.00K | €-3.10 Million | €-2.33 Million | €-1.18 Million | €-881.00K |
| Total Stockholder Equity | €14.90 Million | €12.30 Million | €9.43 Million | €7.46 Million | €7.30 Million |
| Retained Earnings | €9.30 Million | €6.50 Million | €3.84 Million | €1.78 Million | €979.00K |
Biohit Oyj B Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Biohit Oyj B generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-700.00K | €586.00K | €902.00K | €1.85 Million | €-444.00K |
| Capital Expenditures | €600.00K | €400.00K | €248.00K | €59.00K | €33.00K |
| Free Cash Flow | €-1.30 Million | €200.00K | €654.00K | €1.79 Million | €-477.00K |
| Investing Cash Flow | €1.20 Million | €80.00K | €192.00K | €-625.00K | €760.00K |
| Financing Cash Flow | €-300.00K | €-230.00K | €-199.00K | €-186.00K | €-266.00K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | €195.00K | €17.00K |
| Depreciation | €500.00K | €300.00K | €363.00K | €480.00K | €1.99 Million |
| Change in Cash | €-245.00K | €718.00K | €905.00K | €1.02 Million | €64.00K |
Biohit Oyj B Earnings History — EPS Actual vs. Analyst Estimates
Track Biohit Oyj B's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Dec 31, 2022 | -0.02 | — | — |
| Jun 30, 2022 | 0.06 | — | — |
| Dec 31, 2021 | -0.03 | — | — |
| Jun 30, 2021 | -0.07 | — | — |
| Dec 31, 2020 | -0.07 | — | — |
| Jun 30, 2020 | -0.15 | — | — |
| Dec 31, 2019 | -0.05 | — | — |
| Jun 30, 2019 | -0.04 | — | — |